Skip to main content

Advertisement

Log in

Eye movement abnormalities are associated with brainstem atrophy in Wilson disease

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Backgrounds

This study aims to characterize eye movement abnormalities in Wilson disease and examine their association with the degree of brainstem atrophy.

Methods

Twenty patients (10 males, mean age 46.8, SD 8.9 years) with genetically confirmed neurological WD on stable anti-copper treatment and 20 age- and sex-matched healthy subjects were examined. Eye movements, including prosaccade and antisaccade tasks, were evaluated using infrared videooculography. MRI was performed using 1.5 T system, and T2-weighted images were used for the measurement of midbrain and pontine area on mid-sagittal slices. Clinical severity was assessed using the Unified Wilson’s Disease Rating Scale (UWDRS).

Results

Compared to healthy controls, WD patients showed prolonged latencies of horizontal prosaccades and hypometry of both horizontal (p = 0.04) and vertical (p = 0.0046) prosaccades. In the antisaccade task, WD patients showed prolonged latency of both horizontal (p = 0.04) and vertical antisaccades (p = 0.047) and increased error rate of vertical antisaccades (p = 0.04). There is a significant association between midbrain area and horizontal latencies (r = −0.53; p = 0.02) and vertical maximum speed in prosaccades (r = 0.47; p = 0.04). The pons area inversely correlated with horizontal prosaccade and antisaccade latencies (p = 0.007).

Conclusions

We showed impairments of ocular saccades such as prolonged latencies, hypometry, and increased error rate in antisaccades. The strong association between prolonged latencies of prosaccades and the brainstem atrophy suggests that VOG might serve as a sensitive electrophysiological marker of brainstem dysfunction in WD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML (2018) Wilson disease. Nat Rev Dis Primer 4:21. https://doi.org/10.1038/s41572-018-0018-3

    Article  Google Scholar 

  2. Horoupian DS, Sternlieb I, Scheinberg IH (1988) Neuropathological findings in penicillamine-treated patients with Wilson’s disease. Clin Neuropathol 7:62–67

    CAS  PubMed  Google Scholar 

  3. King AD, Walshe JM, Kendall BE, Chinn RJ, Paley MN, Wilkinson ID, Halligan S, Hall-Craggs MA (1996) Cranial MR imaging in Wilson’s disease. AJR Am J Roentgenol 167:1579–1584. https://doi.org/10.2214/ajr.167.6.8956601

    Article  CAS  PubMed  Google Scholar 

  4. Dusek P, Litwin T, Członkowska A (2019) Neurologic impairment in Wilson disease. Ann Transl Med 7:S64. https://doi.org/10.21037/atm.2019.02.43

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bandmann O, Weiss KH, Kaler SG (2015) Wilson’s disease and other neurological copper disorders. Lancet Neurol 14:103–113. https://doi.org/10.1016/S1474-4422(14)70190-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Leśniak M, Członkowska A, Seniów J (2008) Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson’s disease. Mov Disord Off J Mov Disord Soc 23:2067–2073. https://doi.org/10.1002/mds.22276

    Article  Google Scholar 

  7. Tribl GG, Trindade MC, Bittencourt T, Lorenzi-Filho G, Cardoso Alves R, Ciampi de Andrade D, Fonoff ET, Bor-Seng-Shu E, Machado AA, Schenck CH, Teixeira MJ, Barbosa ER (2016) Wilson’s disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med 17:179–185. https://doi.org/10.1016/j.sleep.2015.09.003

    Article  PubMed  Google Scholar 

  8. Jung H-K, Choi SY, Kim J-M, Kim J-S (2013) Selective slowing of downward saccades in Wilson’s disease. Parkinsonism Relat Disord 19:134–135. https://doi.org/10.1016/j.parkreldis.2012.05.023

    Article  PubMed  Google Scholar 

  9. Kirkham TH, Kamin DF (1974) Slow saccadic eye movements in Wilson’s disease. J Neurol Neurosurg Psychiatry 37:191–194. https://doi.org/10.1136/jnnp.37.2.191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ingster-Moati I, Bui Quoc E, Pless M, Djomby R, Orssaud C, Guichard JP, Woimant F (2007) Ocular motility and Wilson’s disease: a study on 34 patients. J Neurol Neurosurg Psychiatry 78:1199–1201. https://doi.org/10.1136/jnnp.2006.108415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Vintonyak O, Gorges M, Müller H-P, Pinkhardt EH, Ludolph AC, Huppertz HJ, Kassubek J (2017) Patterns of eye movement impairment correlate with regional brain atrophy in neurodegenerative parkinsonism. Neurodegener Dis 17:117–126. https://doi.org/10.1159/000454880

    Article  PubMed  Google Scholar 

  12. Semnic R, Svetel M, Dragasevic N, Petrovic I, Kozic D, Marinkovic J, Kostic VS, Sener RN (2005) Magnetic resonance imaging morphometry of the midbrain in patients with Wilson disease. J Comput Assist Tomogr 29:880–883. https://doi.org/10.1097/01.rct.0000181723.61974.51

    Article  PubMed  Google Scholar 

  13. Strecker K, Schneider JP, Barthel H, Hermann W, Wegner F, Wagner A, Schwarz J, Sabri O, Zimmer C (2006) Profound midbrain atrophy in patients with Wilson’s disease and neurological symptoms? J Neurol 253:1024–1029. https://doi.org/10.1007/s00415-006-0151-x

    Article  CAS  PubMed  Google Scholar 

  14. Członkowska A, Tarnacka B, Möller JC, Leinweber B, Bandmann O, Woimant F, Oertel WH (2007) Unified Wilson’s disease rating scale - a proposal for the neurological scoring of Wilson’s disease patients. Neurol Neurochir Pol 41:1–12

    PubMed  Google Scholar 

  15. Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050–2055. https://doi.org/10.1212/01.WNL.0000165960.04422.D0

    Article  CAS  PubMed  Google Scholar 

  16. Antoniades CA, Kennard C (2015) Ocular motor abnormalities in neurodegenerative disorders. Eye Lond Engl 29:200–207. https://doi.org/10.1038/eye.2014.276

    Article  CAS  Google Scholar 

  17. Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376. https://doi.org/10.1136/jnnp.2007.131045

    Article  CAS  PubMed  Google Scholar 

  18. Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK (2007) Sequential MRI changes in Wilson’s disease with de-coppering therapy: a study of 50 patients. Br J Radiol 80:744–749. https://doi.org/10.1259/bjr/48911350

    Article  CAS  PubMed  Google Scholar 

  19. Butinar D, Trontelj JV, Khuraibet AJ, Khan RA, Hussein JM, Shakir RA (1990) Brainstem auditory evoked potentials in Wilson’s disease. J Neurol Sci 95:163–169. https://doi.org/10.1016/0022-510x(90)90239-j

    Article  CAS  PubMed  Google Scholar 

  20. Beh SC, Frohman TC, Frohman EM (2017) Cerebellar control of eye movements. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 37:87–98. https://doi.org/10.1097/WNO.0000000000000456

    Article  Google Scholar 

  21. Robinson FR, Fuchs AF (2001) The role of the cerebellum in voluntary eye movements. Annu Rev Neurosci 24:981–1004. https://doi.org/10.1146/annurev.neuro.24.1.981

    Article  CAS  PubMed  Google Scholar 

  22. Rottach KG, Riley DE, DiScenna AO, Zivotofsky AZ, Leigh RJ (1996) Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol 39:368–377. https://doi.org/10.1002/ana.410390314

    Article  CAS  PubMed  Google Scholar 

  23. Condy C, Wattiez N, Rivaud-Pechoux S et al (2006) Antisaccade deficit after inactivation of the principal sulcus in monkeys. Cereb Cortex 17:221–229. https://doi.org/10.1093/cercor/bhj140

    Article  PubMed  Google Scholar 

  24. Ploner CJ, Gaymard BM, Rivaud-Péchoux S, Pierrot-Deseilligny C (2005) The prefrontal substrate of reflexive saccade inhibition in humans. Biol Psychiatry 57:1159–1165. https://doi.org/10.1016/j.biopsych.2005.02.017

    Article  PubMed  Google Scholar 

  25. Frota NAF, Caramelli P, Barbosa ER (2009) Cognitive impairment in Wilson’s disease. Dement Neuropsychol 3:16–21. https://doi.org/10.1590/S1980-57642009DN30100004

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hegde S, Sinha S, Rao SL et al (2010) Cognitive profile and structural findings in Wilson’s disease: a neuropsychological and MRI-based study. Neurol India 58:708–713. https://doi.org/10.4103/0028-3886.72172

    Article  PubMed  Google Scholar 

  27. Rathbun JK (1996) Neuropsychological aspects of Wilson’s disease. Int J Neurosci 85:221–229

    Article  CAS  Google Scholar 

  28. Goldring J, Fischer B (1997) Reaction times of vertical prosaccades and antisaccades in gap and overlap tasks. Exp Brain Res 113:88–103. https://doi.org/10.1007/bf02454145

    Article  CAS  PubMed  Google Scholar 

  29. Bonnet C, Hanuška J, Rusz J et al (2013) Horizontal and vertical eye movement metrics: what is important? Clin Neurophysiol Off J Int Fed Clin Neurophysiol 124:2216–2229. https://doi.org/10.1016/j.clinph.2013.05.002

    Article  Google Scholar 

  30. Lemos J, Pereira D, Almendra L, Rebelo D, Patrício M, Castelhano J, Cunha G, Januário C, Cunha L, Freire A, Castelo-Branco M (2017) Cortical control of vertical and horizontal saccades in progressive supranuclear palsy: an exploratory fMRI study. J Neurol Sci 373:157–166. https://doi.org/10.1016/j.jns.2016.12.049

    Article  CAS  PubMed  Google Scholar 

  31. Irving EL, Lillakas L (2019) Difference between vertical and horizontal saccades across the human lifespan. Exp Eye Res 183:38–45. https://doi.org/10.1016/j.exer.2018.08.020

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Czech Ministry of Health (15-25602A).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Hanuška J., Dušek P., Rusz J., Ulmanová O., Burgetová A., and Růžička E. The first draft of the manuscript was written by Hanuška J., and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Petr Dušek.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict(s) of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study. 

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hanuška, J., Dušek, P., Rusz, J. et al. Eye movement abnormalities are associated with brainstem atrophy in Wilson disease. Neurol Sci 41, 1097–1103 (2020). https://doi.org/10.1007/s10072-019-04225-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-04225-3

Keywords

Navigation